Inspire Pharmaceuticals, Inc. (ISPH)
$4.98
-0.24 (-4.60%)
| CAPS Rating |
|
|---|---|
| Open | $5.02 |
| Previous Close | $5.22 |
| Daily Range | $4.88 - $5.07 |
| 52-Week Range | $2.59 - $6.54 |
| Market Cap | $409.85M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 165,699 |
| Average Daily Volume | 571,000 |
ISPH
VS S&P 500 (SPY)
How do you think ISPH will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ISPH Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ISPH News and Commentary
- INSV AzaSite® The first ocular treatment of its kind – Blog at The Motley Fool
- Eyeing Opportunities in Micro-Cap Bio-Pharma Index – Blog at The Motley Fool
- Wall Street's Buy List – The Motley Fool
- ISV - probably the most read MF article on a stock, but now down to < $1 ?? – Blog at The Motley Fool
- InSite's Vision of Profits – The Motley Fool
- Investors Tire of Inspire Pharmaceuticals – The Motley Fool
- An Eye-Opening Potential Acquisition – The Motley Fool
Related News and Articles
- A Mostly Meaningless FDA Approval – The Motley Fool
- Biotech Bargains for Your Portfolio – The Motley Fool
- 7 of the Most Efficient Companies on the Planet – The Motley Fool
- 5-Star Stocks Poised to Pop: Diageo – The Motley Fool
- 3 China Profit Plays – The Motley Fool
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
RSS Headlines
Fool UK
